Related Experiment Videos
Levamisole in the treatment of cyclical neutropenia
Postgraduate Medical Journal
|January 1, 1979
Insights
Levamisole treatment improved a child's cyclical neutropenia symptoms, with condition worsening after cessation. Clinical benefits were observed despite no significant changes in neutrophil counts or phagocytic cell function.
Area of Science:
- Pediatric Hematology
- Immunology
- Pharmacology
Background:
- Cyclical neutropenia is a rare blood disorder characterized by recurrent drops in neutrophil counts.
- Neutrophils are crucial white blood cells for fighting infections.
- Levamisole is an immunomodulatory drug with potential applications in various conditions.
Observation:
- A pediatric patient diagnosed with cyclical neutropenia was monitored.
- The patient received treatment with levamisole.
- Clinical status was assessed before, during, and after levamisole therapy.
Findings:
- Marked clinical improvement in the child's condition was noted during levamisole treatment.
- A decline in clinical status was observed after discontinuing levamisole.
- No significant alterations in neutrophil or monocyte counts were associated with treatment.
- Phagocytic cell function tests did not convincingly show improvement during levamisole therapy.
Implications:
- Levamisole may offer clinical benefits in cyclical neutropenia independent of direct effects on neutrophil counts or phagocytic function.
- Further research is warranted to elucidate the mechanisms of levamisole's efficacy in this condition.
- This case highlights the potential of immunomodulatory agents in managing rare hematological disorders.
Abstract:
A child with cyclical neutropenia was observed before and during treatment with levamisole. Marked clinical improvement occurred while on levamisole. Deterioration occurred after stopping treatment. The improvement was not associated with changes in the neutrophil or monocyte counts, nor did tests of phagocytic cell function convincingly demonstrate improvement while the child was on treatment.